XX2KXDBMonitoring of Interstitial Glucose, Wearable Sensor, External Approach, New Technology Group 11
- Billable / Specific Code
- New for FY 2026
XX2KXDB is a billable ICD-10-PCS procedure code for Monitoring of Interstitial Glucose, Wearable Sensor, External Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Monitoring involves determining the level of a physiological or physical function repetitively over a period of time.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | X | Physiological Systems |
| 3 | Operation | 2 | Monitoring |
| 4 | BodyPart | K | Subcutaneous Tissue |
| 5 | Approach | X | External |
| 6 | Device/Substance/Technology | D | Interstitial Glucose, Wearable Sensor |
| 7 | Qualifier | B | New Technology Group 11 |
Code History
Similar Procedure Codes
Questions About XX2KXDB
Is XX2KXDB a billable code?
Yes. XX2KXDB is a complete seven-character ICD-10-PCS code, specific enough to report Monitoring of Interstitial Glucose, Wearable Sensor, External Approach, New Technology Group 11 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XX2KXDB mean?
XX2KXDB breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character X is the Body System (Physiological Systems); the 3rd character 2 is the Operation (Monitoring); the 4th character K is the BodyPart (Subcutaneous Tissue); the 5th character X is the Approach (External); the 6th character D is the Device/Substance/Technology (Interstitial Glucose, Wearable Sensor); the 7th character B is the Qualifier (New Technology Group 11).
